Literature DB >> 18840239

"Special treatment": BiDil, Tuskegee, and the logic of race.

Susan M Reverby1.   

Abstract

BiDil, a drug approved in 2005 by the FDA only for African Americans, was seen by many as almost reparations for the horrors of the Tuskegee Syphilis Study (1932-72) where treatment for black men was denied. The logic of race, however, rather than racism, links BiDil to the past many thought it was escaping.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840239     DOI: 10.1111/j.1748-720X.2008.294.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  5 in total

1.  Grassroots marketing in a global era: more lessons from BiDil.

Authors:  Britt M Rusert; Charmaine D M Royal
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

2.  The Myth of Innate Racial Differences Between White and Black People's Bodies: Lessons From the 1793 Yellow Fever Epidemic in Philadelphia, Pennsylvania.

Authors:  Rana Asali Hogarth
Journal:  Am J Public Health       Date:  2019-08-15       Impact factor: 9.308

3.  Increasing participation in genomic research and biobanking through community-based capacity building.

Authors:  Elizabeth Gross Cohn; Maryam Husamudeen; Elaine L Larson; Janet K Williams
Journal:  J Genet Couns       Date:  2014-09-18       Impact factor: 2.537

4.  Racial categories in medical practice: how useful are they?

Authors:  Lundy Braun; Anne Fausto-Sterling; Duana Fullwiley; Evelynn M Hammonds; Alondra Nelson; William Quivers; Susan M Reverby; Alexandra E Shields
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

5.  The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.

Authors:  Nicole M Franks; Katrina Gipson; Sheri-Ann Kaltiso; Anwar Osborne; Sheryl L Heron
Journal:  Ann Emerg Med       Date:  2021-06-24       Impact factor: 5.721

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.